News

Statins to receive safety guidance

25-Jul-08

Safety warnings will be added to statin packaging and to information sent to GPs from this autumn, says the MHRA.

Warnings about depression, sleep disturbances, memory loss and sexual problems will be published, although no exact date has been confirmed.

Last month, GP reported that GPs were set to abandon NICE guidance on lowering cholesterol levels amid concerns over possible statin side-effects (GP, 6 June).

The guidance recommended GPs aim for targets of 4mmol/l for total cholesterol and 2mmol/l for LDL cholesterol for the secondary prevention of cardiovascular disease (CVD) using 80mg simvastatin.

Dorset GP Dr Graham Archard, who has an interest in CVD, warned: 'If you double up the dose of simvastatin you do not get much more lipid lowering but a lot more side-effects. These can include sleeplessness, lethargy and a feeling of being unwell.'

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP - Make sure you can ace the AKT

Dr Chris Elfes gives a trainer's perspective on how to pass the applied knowledge test. Read more

nMRCGP exam update - Evidence for aspirin use

Contributed by Dr Louise Newson, a GP in the West Midlands. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Show all articles

 

Latest Clinical Articles

Clincal Review: Gout

Contributed by Dr Richard Stevens, consultant rheumatologist, Buckinghamshire Hospitals. Read more

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Show all clinical articles

MIMS Product News

Relistor

New drug - Relistor

Wyeth has launched Relistor (methylnaltrexone bromide) for the treatment of opioid-induced constipat... Read more

Thalidomide available in the UK

Thalidomide, under the name of Thalidomide Pharmion is now commercially available in the UK. Read more

MMR catch-up programme

The DoH has written to healthcare professionals to call for urgent action to help reduce the risk of... Read more

Jobs

 

Job of the Week